Our findings suggest that PNN ablation, via ACAN loss, disrupts microglial function in AD, altering gene expression profiles linked to neuroinflammation and antigen presentation and ultimately exacerbating plaque accumulation. The gene discussed is ACAN; the disease is Alzheimer disease.